(Q37846890)

24 August 2017

1 reference

title

Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control (English)

1 reference

24 August 2017

1 reference

1 reference

3

Jürg Utzinger

0 references

Jennifer Keiser

series ordinal

1

object named as

Jennifer Keiser

1 reference

24 August 2017

2

Katrin Ingram

1 reference

24 August 2017

publication date

24 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

138

1 reference

24 August 2017

issue

12

1 reference

24 August 2017

page(s)

1620-1632

1 reference

An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Developmental changes in the acceptance of the five basic tastes in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Blood sample volumes in child health research: review of safe limits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

A literature review on off-label drug use in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Schistosoma mansoni in infants (aged < 3 years) along the Ugandan shoreline of Lake Victoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Innovative lead discovery strategies for tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Published pediatric randomized drug trials in developing countries, 1996-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

A systematic review of paediatric randomised controlled drug trials published in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Neglected disease research and development: how much are we really spending?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

The drugs we have and the drugs we need against major helminth infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Advances in the discovery and development of trematocidal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Triclabendazole for the treatment of fascioliasis and paragonimiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Developmental pharmacology--drug disposition, action, and therapy in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Age-specific search strategies for Medline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Control of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Africa is desperate for praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Intermittent preventive treatment against malaria: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Unresolved issues in anthelmintic pharmacology for helminthiases of humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Ivermectin: uses and impact 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Triclabendazole progress report, 2005-2009: an advancement of learning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Drug trials in children: problems and the way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Development of and access to products for neglected diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

A breakthrough in R&D; for neglected diseases: new ways to get the drugs we need

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

The economics of pediatric formulation development for off-patent drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Safety of chewable tablets for children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Optimizing oral medications for children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Urinary schistosomiasis in preschool children in settlements around Oyan Reservoir in Ogun State, Nigeria: implications for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Therapeutic drug monitoring in pediatrics: how do children differ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

The impact of gastrointestinal parasites on protein-energy malnutrition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

The bioequivalence of telithromycin administered orally as crushed tablets versus tablets swallowed whole

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Reflections on clinical research in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Lymphatic filariasis and onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Schistosoma mansoni Infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Schistosomiasis in African infants and preschool children: to treat or not to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Paediatric and geriatric drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Infant schistosomiasis in Ghana: A survey in an irrigation community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Stimulation programs for pediatric drug research--do children really benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Global, regional, and national causes of child mortality in 2008: a systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Clinical trials of medication in children, 1996–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Ethical and safety aspects of clinical trials in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

7 January 2021

Paediatric formulations--getting to the heart of the problem

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

7 January 2021

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

7 January 2021

The safety of pharmaceutical excipients

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

7 January 2021

[Dosage forms for children. After the EU Reform]

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

7 January 2021

Paediatric drug development

1 reference

https://api.crossref.org/works/10.1017%2FS0031182011000023

7 January 2021

10.1017/S0031182011000023

Identifiers

DOI

1 reference

24 August 2017

1 reference